Literature DB >> 25598384

Control Outcomes and Exposures for Improving Internal Validity of Nonrandomized Studies.

Stacie B Dusetzina1,2,3,4, M Alan Brookhart4,5, Matthew L Maciejewski6,7.   

Abstract

OBJECTIVE: Control outcomes and exposures can improve internal validity of nonrandomized studies by assessing residual bias in effect estimates. Control outcomes are those expected to have no treatment effect or the opposite effect of the primary outcome. Control exposures are treatments expected to have no effect on the primary outcome. We review examples of control outcomes and exposures from prior studies and provide recommendations for conducting and reporting these analyses. DATA SOURCES AND STUDY
DESIGN: Review in Google Scholar and Medline of research studies employing control outcomes or exposures. We abstracted publication year, control outcome, control exposure, primary outcome, primary exposure, control outcome/exposure effect, proposed source of bias, and causal criteria. PRINCIPAL
FINDINGS: There is inconsistent terminology for these concepts, making study identification challenging. Six of 11 studies found null associations between treatments and negative control outcomes/exposures, providing greater confidence that the primary study findings were not biased. Five studies found unexpected associations, suggesting bias in the primary association.
CONCLUSIONS: The rigor of nonrandomized studies can be improved with inclusion of control outcomes and exposures for bias detection. Given ongoing concern about clinical and policy inferences from nonrandomized studies, we recommend adoption of these measurement tools. © Health Research and Educational Trust.

Keywords:  Control outcomes; control exposures; falsification tests; nonequivalent exposures; nonequivalent outcomes

Mesh:

Year:  2015        PMID: 25598384      PMCID: PMC4600355          DOI: 10.1111/1475-6773.12279

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  32 in total

1.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  A comparison of observational studies and randomized, controlled trials.

Authors:  K Benson; A J Hartz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

Review 3.  Comparison of evidence of treatment effects in randomized and nonrandomized studies.

Authors:  J P Ioannidis; A B Haidich; M Pappa; N Pantazis; S I Kokori; M G Tektonidou; D G Contopoulos-Ioannidis; J Lau
Journal:  JAMA       Date:  2001-08-15       Impact factor: 56.272

4.  Data, design, and background knowledge in etiologic inference.

Authors:  J M Robins
Journal:  Epidemiology       Date:  2001-05       Impact factor: 4.822

5.  Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.

Authors:  Marc L Berger; Nancy Dreyer; Fred Anderson; Adrian Towse; Art Sedrakyan; Sharon-Lise Normand
Journal:  Value Health       Date:  2012 Mar-Apr       Impact factor: 5.725

6.  A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.

Authors:  Marc L Berger; Bradley C Martin; Don Husereau; Karen Worley; J Daniel Allen; Winnie Yang; Nicole C Quon; C Daniel Mullins; Kristijan H Kahler; William Crown
Journal:  Value Health       Date:  2014-03       Impact factor: 5.725

7.  Early statin treatment following acute myocardial infarction and 1-year survival.

Authors:  U Stenestrand; L Wallentin
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

8.  Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.

Authors:  Stacie B Dusetzina; G Caleb Alexander; Rachel A Freedman; Haiden A Huskamp; Nancy L Keating
Journal:  Breast Cancer Res Treat       Date:  2012-11-13       Impact factor: 4.872

9.  Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study.

Authors:  H D Aronow; E J Topol; M T Roe; P L Houghtaling; K E Wolski; A M Lincoff; R A Harrington; R M Califf; E M Ohman; N S Kleiman; M Keltai; R G Wilcox; A Vahanian; P W Armstrong; M S Lauer
Journal:  Lancet       Date:  2001-04-07       Impact factor: 79.321

10.  Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia.

Authors:  Anupam B Jena; Eric Sun; Dana P Goldman
Journal:  J Gen Intern Med       Date:  2012-09-07       Impact factor: 5.128

View more
  20 in total

1.  Value-Based Care for Musculoskeletal Pain: Are Physical Therapists Ready to Deliver?

Authors:  Trevor A Lentz; Adam P Goode; Charles A Thigpen; Steven Z George
Journal:  Phys Ther       Date:  2020-04-17

2.  How Confident Are We about Observational Findings in Healthcare: A Benchmark Study.

Authors:  Martijn J Schuemie; M Soledad Cepeda; Marc A Suchard; Jianxiao Yang; Yuxi Tian; Alejandro Schuler; Patrick B Ryan; David Madigan; George Hripcsak
Journal:  Harv Data Sci Rev       Date:  2020-01-31

3.  Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.

Authors:  Magdalene M Assimon; M Alan Brookhart; Jennifer E Flythe
Journal:  J Am Soc Nephrol       Date:  2019-03-18       Impact factor: 10.121

4.  Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data.

Authors:  Martijn J Schuemie; George Hripcsak; Patrick B Ryan; David Madigan; Marc A Suchard
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-13       Impact factor: 11.205

5.  Negative Control Outcomes: A Tool to Detect Bias in Randomized Trials.

Authors:  Benjamin F Arnold; Ayse Ercumen
Journal:  JAMA       Date:  2016-12-27       Impact factor: 56.272

6.  The relationship between prior psychiatric diagnosis and brain cancer diagnosis in the U.S. military health system.

Authors:  Julie A Bytnar; Jie Lin; Brett J Theeler; Ann I Scher; Craig D Shriver; Kangmin Zhu
Journal:  Cancer Causes Control       Date:  2022-07-15       Impact factor: 2.532

7.  The Association Between Medicare Low-Income Subsidy and Anticancer Treatment Uptake in Advanced Lung Cancer.

Authors:  Yi-Ting Chou; Joel F Farley; Thomas E Stinchcombe; Amber E Proctor; Jennifer Elston Lafata; Stacie B Dusetzina
Journal:  J Natl Cancer Inst       Date:  2020-06-01       Impact factor: 13.506

8.  A Selective Review of Negative Control Methods in Epidemiology.

Authors:  Xu Shi; Wang Miao; Eric Tchetgen Tchetgen
Journal:  Curr Epidemiol Rep       Date:  2020-10-15

9.  The importance and implications of comparator selection in pharmacoepidemiologic research.

Authors:  Monica D'Arcy; Til Stürmer; Jennifer L Lund
Journal:  Curr Epidemiol Rep       Date:  2018-07-06

10.  Use of Proton Pump Inhibitors Increases Risk of Incident Kidney Stones.

Authors:  Michael Simonov; Erica A Abel; Melissa Skanderson; Amir Masoud; Ronald G Hauser; Cynthia A Brandt; Francis P Wilson; Loren Laine
Journal:  Clin Gastroenterol Hepatol       Date:  2020-03-06       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.